BEIJING, Feb 21 (Reuters) - China's food and drugs regulatory body said it had suspended its electronic drug monitoring system, a platform operated by Alibaba Health Information Technology Ltd, while it drafts amendments to regulations monitoring pharmaceutical sales.
Read more
No comments:
Post a Comment